Cicada, officially known as BA.3.2, is not a simple repeat of the past. First spotted in South Africa in late 2024, it has since appeared from the US and UK to Japan and Kenya, often detected only after it has already spread. With up to 75% variation from earlier strains, it looks unfamiliar to the immune system, raising fears about how easily it can dodge existing defenses. Yet doctors on the front lines report something crucial: so far, it does not appear more deadly than previous variants.
